Clinical trial
Testosterone and Alendronate in Hypogonadal Men
NCT01460654 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Testosterone and Alendronate in Hypogonadal Men
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypogonadism, osteopenia, osteoporosis